BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33628362)

  • 1. I-
    Cao Y; Li L; Liu Y; Chen G; Tao Z; Wang R; Chen W
    Oxid Med Cell Longev; 2021; 2021():6429197. PubMed ID: 33628362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKK Epsilon Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice by Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Chai H; Tao Z; Qi Y; Qi H; Chen W; Xu Y; Zhang L; Chen H; Chen X
    Oxid Med Cell Longev; 2020; 2020():3602824. PubMed ID: 32064021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
    J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.
    Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L
    J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
    Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
    Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
    Ebrahimian T; Sairam MR; Schiffrin EL; Touyz RM
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1481-8. PubMed ID: 18676690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice.
    He S; Nian F; Chen W; Yin L; Auchoybur ML; Tao Z; Tang S; Chen X
    Biomed Pharmacother; 2019 Jan; 109():1287-1295. PubMed ID: 30463808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
    Khan SA; Dong H; Joyce J; Sasaki T; Chu ML; Tsuda T
    Lab Invest; 2016 Jul; 96(7):773-83. PubMed ID: 27111286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway.
    Liu Y; Xu Y; Yao Y; Cao Y; Chen G; Cai Y; Chen W; Chen X; Qiu Z
    Front Physiol; 2022; 13():934899. PubMed ID: 35991177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.
    Li N; Wang HX; Han QY; Li WJ; Zhang YL; Du J; Xia YL; Li HH
    J Mol Cell Cardiol; 2015 Feb; 79():303-14. PubMed ID: 25526681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
    Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
    Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.